Home › Funds › MILFORD FUNDS LTD › BSX
MILFORD FUNDS LTD position in BSX
BOSTON SCIENTIFIC CORP · Health Care
MILFORD FUNDS LTD reported holding 1,066,869 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$46.6M, representing 0.69% of its reported portfolio and ranking #44 among its reported holdings. MILFORD FUNDS LTD has disclosed BSX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How MILFORD FUNDS LTD's BSX position evolved
MILFORD FUNDS LTD first disclosed a stake in BSX in Q4 2025 at 815,279 shares (US$77.7M). The position peaked in Q1 2026 at 2,210,221 shares, worth US$138.7M. Across 4 filings, MILFORD FUNDS LTD increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,066,869 shares valued at US$46.6M — a reduction of -1,102,615 shares quarter over quarter.. Notable position changes include a 171% increase in Q1 2026 (shares fell 32% over the following quarter), a 51% trim in Q3 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 815.28K | $77.74M | New |
| Q1 2026 | 2.21M | $138.69M | Add |
| Q2 2026 | 2.17M | $92.59M | Reduce |
| Q3 2026 | 1.07M | $46.57M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BSX and 13F data
BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 20 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.56B), MFS Investment Management (US$2.29B), Arrowstreet Capital (US$1.24B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BSX
- PRIMECAP MANAGEMENT CO/CA/ 58.62M sh · $2.56B · Q3 2026
- MFS Investment Management 43.05M sh · $2.29B · Q3 2026
- Arrowstreet Capital 28.47M sh · $1.24B · Q3 2026
- D. E. Shaw & Co 27.27M sh · $1.16B · Q2 2026
- AQR CAPITAL MANAGEMENT LLC 24.32M sh · $1.06B · Q3 2026
- Two Sigma Investments 20.01M sh · $873.30M · Q3 2026
More on MILFORD FUNDS LTD
FAQ
How long has MILFORD FUNDS LTD held BSX?
MILFORD FUNDS LTD has disclosed BSX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is MILFORD FUNDS LTD's current position in BSX?
As of Q3 2026, MILFORD FUNDS LTD holds 1.07M shares of BSX (BOSTON SCIENTIFIC CORP), valued at $46.57M, representing 0.69% of its reported portfolio and ranking #44.
Has MILFORD FUNDS LTD been buying or selling BSX?
In the latest 13F filing (Q3 2026), MILFORD FUNDS LTD reduced its position in BSX. The position peaked in Q1 2026 at 2.21M shares.
Which other funds hold BSX?
Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, MFS Investment Management, Arrowstreet Capital, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.